Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Inventory (2021 - 2025)

HeartSciences' Change in Inventory history spans 5 years, with the latest figure at $7778.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 21.18% year-over-year to $7778.0; the TTM value through Jan 2026 reached $5138.0, up 128.34%, while the annual FY2025 figure was $21088.0, 144.7% up from the prior year.
  • Change in Inventory reached $7778.0 in Q4 2025 per HSCS's latest filing, up from -$760.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $13860.0 in Q3 2024 to a low of -$41099.0 in Q2 2024.
  • Average Change in Inventory over 5 years is -$6131.3, with a median of -$760.0 recorded in 2023.
  • Peak YoY movement for Change in Inventory: surged 110.49% in 2022, then tumbled 7372.55% in 2024.
  • A 5-year view of Change in Inventory shows it stood at -$23397.0 in 2021, then skyrocketed by 115.09% to $3530.0 in 2022, then tumbled by 115.58% to -$550.0 in 2023, then skyrocketed by 1894.18% to $9868.0 in 2024, then decreased by 21.18% to $7778.0 in 2025.
  • Per Business Quant, the three most recent readings for HSCS's Change in Inventory are $7778.0 (Q4 2025), -$760.0 (Q3 2025), and -$1880.0 (Q2 2025).